Log in to save to my catalogue

Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL

Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2fda8b3a5f5d4aefa4981146857abfa2

Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL

About this item

Full title

Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL

Publisher

United States: Elsevier Inc

Journal title

Molecular therapy. Nucleic acids, 2016, Vol.5 (3), p.e289-e289, Article e289

Language

English

Formats

Publication information

Publisher

United States: Elsevier Inc

More information

Scope and Contents

Contents

TNF-related apoptosis-inducing ligand (TRAIL) is a promising antitumor agent for its remarkable ability to selectively induce apoptosis in cancer cells, without affecting the viability of healthy bystander cells. The TRAIL tumor suppressor pathway is deregulated in many human malignancies including lung cancer. In human non-small cell lung cancer (...

Alternative Titles

Full title

Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_2fda8b3a5f5d4aefa4981146857abfa2

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2fda8b3a5f5d4aefa4981146857abfa2

Other Identifiers

ISSN

2162-2531

E-ISSN

2162-2531

DOI

10.1038/mtna.2016.5

How to access this item